21st Century Oncology is categorized under Rehabilitation Center, Outpatient Treatment in Fort Myers, FL and active since 2010.
21st Century Oncology was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact at the company’s branch by writing to 12165 Metro Parkway, Fort Myers, Florida FL 33966 or by phoning (239) 561-7050. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | 21st Century Oncology |
Address: | 12165 Metro Parkway, Fort Myers, Florida 33966 |
Phone Number: | (239) 561-7050 |
Website Address: | 21stcenturyoncology.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 6223100 |
Share This Business: |
21st Century Oncology was started in 2010 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact for inquiries that concern 21st Century Oncology by calling the company number (239) 561-7050, as your correspondence is most welcome. Additionally, the physical location of the branch of 21st Century Oncology can be found at the coordinates 26.56626,-81.85296 as well as the street address 12165 Metro Parkway in Fort Myers, Florida 33966.
For its online presence, you may visit 21st Century Oncology’s website at 21stcenturyoncology.com and engage with its social media outlets through on Twitter and on Facebook.